Latest Intelligence on Oncology

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

AVAX: cell banking heralds new era in cancer care

Published By Datamonitor
09 Oct 2000
Expert View
Expert View

Inoculating the cancer market

Published By Datamonitor
13 Oct 2000
CommentWire
CommentWire

Myriad Genetics: an unusually successful collaborator

Published By Datamonitor
23 Oct 2000
CommentWire
CommentWire

Antisoma: changing product range, but not direction

Published By Datamonitor
30 Oct 2000
CommentWire
CommentWire

KS BioMedix: an alternative route to the marketplace

Published By Datamonitor
06 Nov 2000
CommentWire
CommentWire

Novartis: Femara and the rise of the aromatase inhibitors

Published By Datamonitor
13 Nov 2000
CommentWire
CommentWire

AstraZeneca: image boost only from new tamoxifen study

Published By Datamonitor
20 Nov 2000
CommentWire
CommentWire

Axcan: promising results, but still a long way to go

Published By Datamonitor
27 Nov 2000
CommentWire
CommentWire

Pfizer: Viagra a boost for prostate cancer patients

Published By Datamonitor
14 Dec 2000
CommentWire
CommentWire

AEterna: new niche for Neovastat

Published By Datamonitor
22 Dec 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.